Trial intelligence / Profile preview

NSAS-CC: Adjuvant UFT vs Surgery Alone in Dukes C Bowel Cancer

jRCT1080220056Phase 3

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Sep 2005
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of tegafur + uracil in colorectal cancer (CRC) (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd.

02

Drugs

tegafur + uracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on jRCT1080220056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call